Fall Skin Care Sale

Life Extension Magazine

Life Extension Magazine February 2014
Report  

Targeting Appetite Hormones To Prevent Food Cravings

By Michael Downey

Animal Data Supports Lamon Extract

The early studies on the Italian Lamon variety Borlotto bean extract were conducted on laboratory animal models.

Different rat groups were supplemented with very high doses of Lamon variety bean extract and then provided with access to regular food pellets, a starch-enriched diet, and a highly palatable chocolate-flavored beverage.23 The results showed that there were decreases in blood glucose levels, food intake, and body weight gain, all varying by the dose of Italian Lamon variety Borlotto bean extract.23

In one of these experiments, scientists pretreated rats with a drug that interferes with receptors for the appetite-suppressing hormone CCK. The drug blocked Lamon bean extract’s food reduction effect, demonstrating that Lamon extract works in part by modulating CCK signaling.23

To learn more about the hunger-reducing effects of Italian Lamon variety Borlotto bean extract, scientists conducted additional studies. Rats were trained to press a lever to receive as much of a chocolate-flavored beverage as they wished.35 Then Lamon variety bean extract was administered in differing dosage ranges. In a dose-dependent manner, Lamon bean extract reduced lever-pressing by up to 40% indicating that the rats had a sense of satiety and did not want more of the chocolate-flavored beverage.35

This finding was repeated in two almost-identical studies,one of which also found an up to 30% reduction in food intake—a reduction that persisted for a full 24 hours!36,37

This appetite-suppressing effect was further tested on obese rats. They were weighed after each of three separate rounds of 5-day treatment periods followed by a 20-day washout period.26 After each treatment period, in a dose-dependent manner, the different doses of Italian Lamon variety Borlotto bean extract reduced daily food intake by an average of 20-35% and resulted in reduced body weight.26

When rats are fed carbohydrates, they experience blood sugar spikes—just as humans do. Researchers reported that the Italian Lamon variety Borlotto bean extract effectively blocks absorption of carbohydrates in animals by inhibiting the alpha-amylase enzyme.26

In one experiment on after-meal glucose response, scientists first put obese rats through a food-deprivation period. Then, they were given different doses of the Italian Lamon variety Borlotto bean extract and immediately allowed access to a fixed amount of starch-enriched chow.26 Testing after the meal showed that in a dose-dependent manner, the Italian Lamon variety Borlotto bean extract suppressed carbohydrate-induced after-meal glucose spikes.26

The doses used in these rat studies were far higher than needed in the successful human clinical trials. This helped demonstrate the safety of the Italian Lamon variety Borlotto bean extract. The impressive human studies only required 100 mg of the Italian Lamon variety Borlotto bean extract taken two times daily.3

New! Italian Lamon Variety Borlotto Bean Extract
New! Italian Lamon Variety Borlotto Bean Extract

For many years, various bean extracts have been used in high doses to suppress alpha-amylase.3,23

While this is one mechanism that can help facilitate fat loss, it does not affect hunger hormones that are a root cause of unwanted weight gain.

Scientists have developed a novel extract from the Italian Lamon variety Borlotto bean that provides specific constituents (phytoagglutinins) that suppress ghrelin and promote CCK, GLP1 and PYY to help keep food cravings and hunger under control.2,3,23-25

This new Lamon variety Borlotto bean extract also provides the constituent responsible for alpha-amylase inhibition.3

The Italian Lamon variety Borlotto bean extract is obtained from a selected breed of beans characterized by a specific ratio between amylase-inhibiting and satiety-inducing factors. It is then highly purified and standardized to maximize efficacy for optimal appetite hormone balance using a low dose ( 100 mg twice a day).3

By suppressing ghrelin, promoting CCK, GLP1, PYY, and inhibiting amylase, long term weight loss compliance with success is now more easily attainable.2,3,23-25

Inhibiting Carbohydrate Absorption

Appetite hormones are not the only factor in weight gain. Excess carbohydrate calories in the modern Western diet undermine the best efforts to maintain healthy levels of body weight.38

Excess blood glucose leads to increased insulin—and increased insulin contributes to greater difficulty burning stored body fat as fuel.39 It is also involved in the body storing more excess carbohydrate calories as unsightly fat.39 Rapid sugar absorption contributes to after-meal glucose surges, impaired sugar control, and sharply increased disease risk.

The good news is that in addition to its ability to rebalance appetite hormones, Italian Lamon variety bean extract also impedes the enzyme alpha-amylase which breaks down dietary starch into simple sugars that are rapidly absorbed in the small intestine.3,23

Blocking alpha-amylase inhibits the breakdown of starches and slows the rate at which free sugars are absorbed, thereby blunting glucose spikes.26 This provides a practical approach to help lower glucose levels, improve age-related markers of health, and regain glycemic control.

Italian Lamon variety Borlotto bean extract helps counteract undesired weight gain through two distinct mechanisms: it rebalances appetite signaling hormones and it inhibits excess carbohydrate absorption.

Summary

Since obesity involves a higher mortality risk than being of normal weight,40 successful weight loss can be a matter of life and death.

But disordered appetite hormones sabotage weight loss by causing chronic hunger, a reduced feeling of satiety, and greater cravings for unhealthy food choices. The most effective option to regulate appetite hormones is gastric bypass surgery—which is costly, uncomfortable, and substantially risky.

Clinical studies now demonstrate that a proprietary extract from the Italian Lamon variety Borlotto bean is a safe, effective nutritional supplement that modulates ghrelin and other appetite hormones, effectively blocking hunger while increasing feelings of food satisfaction and fullness.2,3,23-25

Italian Lamon variety Borlotto bean extract also inhibits the enzyme (alpha-amylase) that converts carbohydrates into sugar.3,23 This impedes the after-meal glucose surge that has been implicated in increased risks of a number of degenerative conditions.29-34

Based on clinical trial data, this new Italian Lamon variety Borlotto bean extract may help aging individuals achieve healthy body weight and optimize glucose control, thereby reducing disease risks, improving appearance, and boosting longevity!

If you have any questions on the scientific content of this article, please call a Life Extension® Health Advisor at 1-866-864-3027.

References

  1. Goldstone AP. The hypothalamus, hormones, and hunger: alterations in human obesity and illness. Prog Brain Res. 2006;153:57-73.
  2. Spadafranca A, Rinelli S, Riva A, et al. Phaseolus vulgaris extract affects glycometabolic and appetite control in healthy human subjects. Br J Nutr. 2013 May;109(10):1789-95.
  3. Irvine3 Vascular Laboratories & Microcirculation. Analysis of the results obtained from use of product Beanblock® in the treatment of overweight, 2013.
  4. Available at: http://www.elsevierhealth.co.uk/media/us/samplechapters/9781416002451/9781416002451.pdf. Accessed November 7, 2013.
  5. Carlson MJ, Cummings DE. Prospects for an anti-ghrelin vaccine to treat obesity. Mol Interv. 2006 Oct;6(5):249-52.
  6. Näslund E, Barkeling B, King N, et al. Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men. Int J Obes Relat Metab Disord. 1999 Mar;23(3):304-11.
  7. Halford JC, Cooper GD, Dovey TM. The pharmacology of human appetite expression. Curr Drug Targets. 2004 Apr;5(3):221-40.
  8. Serra-Prat M, Palomera E, Clave P, Puig-Domingo M. Effect of age and frailty on ghrelin and cholecystokinin responses to a meal test. Am J Clin Nutr. 2009 May;89(5):1410-7.
  9. Blum K, Gardner E, Oscar-Berman M, Gold M. “Liking” and “wanting” linked to Reward Deficiency Syndrome (RDS): hypothesizing differential responsivity in brain reward circuitry. Curr Pharm Des. 2012;18(1):113-8.
  10. Kroemer NB, Krebs L, Kobiella A, et al. Fasting levels of ghrelin covary with the brain response to food pictures. Addict Biol. 2013 Sep;18(5):855-62.
  11. Terashi M, Asakawa A, Harada T, et al. Ghrelin reactive autoantibodies in restrictive anorexia nervosa. Nutrition. 2011 Apr;27(4):407-13.
  12. Perreault M, Istrate N, Wang L, Nichols AJ, Tozzo E, Stricker-Krongrad A. Resistance to the orexigenic effect of ghrelin in dietary-induced obesity in mice: reversal upon weight loss. Int J Obes Relat Metab Disord. 2004 Jul;28(7):879-85.
  13. Briggs DI, Lockie SH, Wu Q, Lemus MB, Stark R, Andrews ZB. Calorie-restricted weight loss reverses high-fat diet-induced ghrelin resistance, which contributes to rebound weight gain in a ghrelin-dependent manner. Endocrinology. 2013 Feb;154(2):709-17.
  14. Wang TN, Chang WT, Chiu YW, et al. Relationships between changes in leptin and insulin resistance levels in obese individuals following weight loss. The Kaohsiung journal of medical sciences. 2013 Aug;29(8):436-43.
  15. Available at: http://win.niddk.nih.gov/publications/gastric.htm. Accessed November 7, 2013.
  16. Nannipieri M, Baldi S, Mari A, et al. Roux-en-Y gastric bypass and sleeve gastrectomy: Mechanisms of diabetes remission and role of gut hormones. J Clin Endocrinol Metab. 2013 Nov;98(11):4391-9.
  17. Karamanakos SN, Vagenas K, Kalfarentzos F, Alexandrides TK. Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study. Ann Surg. 2008 Mar;247(3):401-7.
  18. Chronaiou A, Tsoli M, Kehagias I, Leotsinidis M, Kalfarentzos F, Alexandrides TK. Lower ghrelin levels and exaggerated postprandial peptide-YY, glucagon-like peptide-1, and insulin responses, after gastric fundus resection, in patients undergoing Roux-en-Y gastric bypass: a randomized clinical trial. Obes Surg. 2012 Nov;22(11):1761-70.
  19. Papamargaritis D, Panteliou E, Miras AD, le Roux CW. Mechanisms of weight loss, diabetes control and changes in food choices after gastrointestinal surgery. Curr Atheroscler Rep. 2012 Dec;14(6):616-23.
  20. Peterli R, Steinert RE, Woelnerhanssen B, et al. Metabolic and hormonal changes after laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy: a randomized, prospective trial. Obes Surg. 2012 May;22(5):740-8.
  21. Available at: http://www.hindawi.com/journals/ijpep/2010/217267/#B41. Accessed November 18, 2013.
  22. Ionut V, Burch M, Youdim A, Bergman RN. Gastrointestinal hormones and bariatric surgery induced weight loss. Obesity (Silver Spring). 2013 Mar 20.
  23. Fantini N, Cabras C, Lobina C, et al. Reducing effect of a Phaseolus vulgaris dry extract on food intake, body weight, and glycemia in rats. J Agric Food Chem. 2009 Oct 14;57(19):9316-23.
  24. Carai MA, Fantini N, Loi B, Colombo G, Riva A, Morazzoni P. Potential efficacy of preparations derived from Phaseolus vulgaris in the control of appetite, energy intake, and carbohydrate metabolism. Diabetes Metab Syndr Obes. 2009;2:145-53.
  25. Nilsson A, Johansson E, Ekstrom L, Bjorck I. Effects of a brown beans evening meal on metabolic risk markers and appetite regulating hormones at a subsequent standardized breakfast: a randomized cross-over study. PLoS One. 2013;8(4):e59985.
  26. Carai MA, Fantini N, Loi B, et al. Multiple cycles of repeated treatments with a Phaseolus vulgaris dry extract reduce food intake and body weight in obese rats. Br J Nutr. 2011 Sep;106(5):762-8.
  27. Pusztai A, Grant G, Buchan WC, Bardocz S, de Carvalho AF, Ewen SW. Lipid accumulation in obese Zucker rats is reduced by inclusion of raw kidney bean ( Phaseolus vulgaris) in the diet. Br J Nutr. 1998 Feb;79(2):213-21.
  28. Santoro LG, Grant G, Pusztai A. Effects of short-term feeding of rats with a highly purified phaseolin preparation. Plant Foods Hum Nutr. 1997;51(1):61-70.
  29. Emerging Risk Factors Collaboration, Seshasai SR, Kaptoge S, et al. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med. 2011 Mar 3;364(9):829-41.
  30. Crane PK, Walker R, Hubbard RA, et al. Glucose levels and risk of dementia. N Engl J Med. 2013 Aug 8;369(6):540-8.
  31. Sarwar N, Aspelund T, Eiriksdottir G, et al. Markers of dysglycaemia and risk of coronary heart disease in people without diabetes: Reykjavik prospective study and systematic review. PLoS Med. 2010 May 25;7(5):e1000278.
  32. Dudziak K, Regulska-Ilow B. The importance of glycemic load of the diet in the development of cancer. Postepy Hig Med Dosw (Online). 2013 May 21;67:449-62.
  33. Brand-Miller JC. Glycemic load and chronic disease. Nutr Rev. 2003 May;61(5 Pt 2):S49-55.
  34. Howlett J, Ashwell M. Glycemic response and health: summary of a workshop. Am J Clin Nutr. 2008 Jan;87(1):212S-216S.
  35. Maccioni P, Colombo G, Riva A, et al. Reducing effect of a Phaseolus vulgaris dry extract on operant self-administration of a chocolate-flavoured beverage in rats. Br J Nutr. 2010 Sep;104(5):624-8.
  36. Zaru A, Maccioni P, Riva A, et al. Reducing effect of a combination of Phaseolus vulgaris and Cynara scolymus extracts on operant self-administration of a chocolate-flavoured beverage in rats. Phytother Res. 2012 Aug 17.
  37. Loi B, Fantini N, Colombo G, et al. Reducing effect of an extract of Phaseolus vulgaris on food intake in mice—focus on highly palatable foods. Fitoterapia. 2013 Mar;85:14-9.
  38. Berrino F. Western diet and Alzheimer’s disease. Epidemiol Prev. 2002 May-Jun;26(3):107-15.
  39. Cordain L, Eaton SB, Sebastian A, et al. Origins and evolution of the Western diet: health implications for the 21st century. Am J Clin Nutr. 2005 Feb;81(2):341-54.
  40. Available at: http://www.oecd.org/dataoecd/1/61/49716427.pdf.Accessed November 11, 2013.